Flowers Foods, Inc. (NYSE:FLO) Q1 2025 Earnings Call Transcript May 16, 2025 Flowers Foods, Inc. misses on earnings expectations. Reported EPS is $0.35 EPS, expectations were $0.38. Operator: Good morning, and thank you for standing by. Welcome to the Flowers Foods’ First Quarter 2025 Results Conference Call. Please be advised that today’s event is being … Read more
Someone’s weight can be an extremely sensitive topic, and in some scenarios, it may be the make or break in a relationship. With one Brazilian influencer, that was unfortunately the case. Débora Dunhill revealed to local news outlet O Globo that her former boyfriend had injected weight loss medication into her body while she slept … Read more
ADVANCEMENTS IN GLP-1 ANALOG FORMULATION DEVELOPMENT: OVERCOMING CHALLENGES IN ORAL DELIVERYFebruary 14, 2025By Adare Pharmaceuticals Obesity is a significant global health challenge that requires lifestyle changes and effective pharmacological treatments to overcome. Human glucagon-like peptide 1 (GLP-1) analogs, also called incretin mimetics, have emerged as a promising obesity treatment option. Additionally, oral GLP-1 formulations represent a … Read more
President Donald Trump’s bold executive order on drug pricing isn’t just policy—it’s a revolution in healthcare affordability. The plan is simple yet transformative: ensure Americans pay no more for medications than citizens of other wealthy nations. Consider this stark reality: a GLP-1 drug costing $88 in London commands $1,000 in the United States. Even after … Read more
Stepping onto the scale is about as American as eating apple pie, watching baseball, and visiting the drive-thru at McDonald’s. Since U.S. adult obesity rates have doubled since 1990 (from 21.2% in 1990 to 43.8% in 2022 for women, and 16.9% to 41.6% in 2022 for men), you’d think a weight-loss company like Weight Watchers … Read more
GLP-1 receptor agonists (GLP-1 RAs), medications that help control type 2 diabetes and obesity, can have a profound impact on physical wellness – but what about mental health? Some examples of these medications include semaglutides, such as Ozempic and Wegovy, and liraglutide, like Victoza and Saxenda. Various studies have pointed toward GLP-1 RAs causing mental … Read more
Our country is obsessed with weight loss. From marathon gym sessions and trendy detox teas to the latest GLP-1 injections, people will try just about anything to get lean. But ask any legit health expert and they’ll tell you the truth: There’s no shortcut to losing weight. The only real way to drop pounds—and keep … Read more
FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
